<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ppharm</journal-id><journal-title-group><journal-title xml:lang="ru">Педиатрическая фармакология</journal-title><trans-title-group xml:lang="en"><trans-title>Pediatric pharmacology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1727-5776</issn><issn pub-type="epub">2500-3089</issn><publisher><publisher-name>Издательство «ПедиатрЪ»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15690/pf.v17i5.2161</article-id><article-id custom-type="elpub" pub-id-type="custom">ppharm-1898</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Клинические факторы риска тромбообразования у детей после коррекции врожденных пороков сердца</article-title><trans-title-group xml:lang="en"><trans-title>Clinical Risk Factors of Thrombosis in Children after Congenial Heart Diseases Management</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3395-2812</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ластовка</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Lastovka</surname><given-names>Vasily A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6667-9472</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тепаев</surname><given-names>Р. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Tepaev</surname><given-names>Rustem F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8311-9506</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гордеева</surname><given-names>О. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Gordeeva</surname><given-names>Olga B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гордеева Ольга Борисовна, кандидат медицинский наук, доцент кафедры факультетской педиатрии педиатрического факультета ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России, заведующая отделом научных основ гемостаза Научно-исследовательский институт педиатрии и охраны здоровья детей ЦКБ РАН Министерства науки и высшего образования РФ</p><p>119333, Москва, ул. Фотиевой, д. 10тел.: +7 (499) 400-47-33 </p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">obr@yandex.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4443-345X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Биджиев</surname><given-names>А. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Bidzhiev</surname><given-names>Anuar R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4218-5309</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Федяева</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Fedyaeva</surname><given-names>Elena A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-5"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр здоровья детей</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Center of Children’s Health</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр здоровья детей; Первый Московский государственный медицинский университет им. И.М. Сеченова (Сеченовский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Center of Children’s Health; Sechenov First Moscow State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Российский национальный исследовательский медицинский университет им. Н.И. Пирогова; НИИ педиатрии и охраны здоровья детей ЦКБ РАН</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pirogov Russian National Research Medical University; Research Institute of Pediatrics and Children’s Health in «Central Clinical Hospital of the Russian Academy of Sciences»</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>НИИ педиатрии и охраны здоровья детей ЦКБ РАН</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Research Institute of Pediatrics and Children’s Health in «Central Clinical Hospital of the Russian Academy of Sciences»</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-5"><aff xml:lang="ru"><institution>Первый Московский государственный медицинский университет им. И.М. Сеченова (Сеченовский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Sechenov First Moscow State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>21</day><month>11</month><year>2020</year></pub-date><volume>17</volume><issue>5</issue><fpage>424</fpage><lpage>428</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ластовка В.А., Тепаев Р.И., Гордеева О.Б., Биджиев А.Р., Федяева Е.А., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Ластовка В.А., Тепаев Р.И., Гордеева О.Б., Биджиев А.Р., Федяева Е.А.</copyright-holder><copyright-holder xml:lang="en">Lastovka V.A., Tepaev R.F., Gordeeva O.B., Bidzhiev A.R., Fedyaeva E.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pedpharma.ru/jour/article/view/1898">https://www.pedpharma.ru/jour/article/view/1898</self-uri><abstract/><trans-abstract xml:lang="en"><p>Background. Development of thrombotic complications in the postoperative period worsens the course of the disease and increases mortality of children operated for congenital heart diseases (CDC). There is limited data on clinical risk factors of thrombosis after CDCs surgical correction in modern literature. In our opinion, there are several promising factors that have not been studied as predictors of thrombosis in children with CDCs. Aim of the study is to analyze possible effect of patient clinical characteristics on development of thrombotic complications in infants after surgical treatment of CDC. Methods. We have studied data of 156 children aged from birth to 11 months 29 days (median age — 5 months) with CDCs operated under artificial circulation. Following indexes were studied in all patients: age, surgical risk according to RACHS-1 (Risk adjustment for congenital heart surgery), anesthesia duration, surgery duration, aortic cross-clamping time, artificial circulation duration, gestation period, body weight and height at the time of surgery. Results. Thrombosis was diagnosed in 44 patients (28.2%) in the postoperative period. Thromboses of various localizations were found during the patients’ examination: cerebral, intracardiac, limbs vessels, etc. It was revealed that thrombosis detection in patients with RACHS-1 &gt;3 has increased in 2.84 times (95% CI: 1.36-5.92), at anesthesia duration &gt;220 minutes — in 2.64 times (95% CI: 1.15-6.05), at surgery duration &gt;150 minutes — in 3.36 times (95% MD: 1.51-7.5), at aortic cross-clamping time &gt;32 minutes – in 3.23 times (95% CI: 1.45-7.32), at artificial circulation duration &gt;70 minutes — in 3.43 times (95% MD: 1.6-7.34), with gestation period less than 39 weeks — in 2.44 times (95% CI: 1.18-5.03), with child’s weight less than 5.000 grams – in 4.3 times (95% CI: 2.02-9.15), with child’s height less than 60 centimeters — in 4.57 times (95% CI: 2.15-9.73), and at the age less than 3 months old — in 2.31 times (95% CI: 1.08-4.92). Conclusion. RACHS-1 &gt;3, anesthesia duration &gt;220 minutes, surgery duration &gt;150 minutes, aortic cross-clamping time &gt;32 minutes, artificial circulation duration &gt;70 minutes, gestation period less than 39 weeks, weight at the time of surgery less than 5000 grams, height at the time of surgery less than 60 centimeters, and age under 3 months increases the risk of thrombotic complications in postoperative period.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>тромбоз</kwd><kwd>искусственное кровообращение</kwd><kwd>врожденные пороки сердца</kwd><kwd>возраст</kwd><kwd>RACHS-1</kwd><kwd>длительность анестезии</kwd><kwd>длительность операции</kwd><kwd>время пережатия аорты</kwd><kwd>длительность искусственного кровообращения</kwd><kwd>гестационный срок</kwd><kwd>масса тела</kwd><kwd>рост</kwd></kwd-group><kwd-group xml:lang="en"><kwd>thrombosis</kwd><kwd>artificial circulation</kwd><kwd>congenital heart diseases</kwd><kwd>age</kwd><kwd>RACHS-1</kwd><kwd>anesthesia duration</kwd><kwd>surgery duration</kwd><kwd>aortic cross-clamping time</kwd><kwd>artificial circulation duration</kwd><kwd>gestation period</kwd><kwd>weight</kwd><kwd>height</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Не указан.</funding-statement><funding-statement xml:lang="en">Not specified.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Andrew ME, Monagle P, deVeber G, Chan AK. Thromboembolic disease and antithrombotic therapy in newborns. Hematology Am Soc Hematol Educ Program. 2001;1:358–374. doi: 10.1182/asheducation-2001.1.358.</mixed-citation><mixed-citation xml:lang="en">Andrew ME, Monagle P, deVeber G, Chan AK. Thromboembolic disease and antithrombotic therapy in newborns. Hematology Am Soc Hematol Educ Program. 2001;1:358–374. doi: 10.1182/asheducation-2001.1.358.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Gruenwald CE, Manlhiot C, Crawford-Lean L, et al. Management and monitoring of anticoagulation for children undergoing cardiopulmonary bypass in cardiac surgery. J Extra Corpor Technol. 2010;42(1):9–19.</mixed-citation><mixed-citation xml:lang="en">Gruenwald CE, Manlhiot C, Crawford-Lean L, et al. Management and monitoring of anticoagulation for children undergoing cardiopulmonary bypass in cardiac surgery. J Extra Corpor Technol. 2010;42(1):9–19.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Monagle P, Barnes C, Ignjatovic V, et al. Developmental haemostasis: impact for clinical haemostasis laboratories. Thromb Haemost. 2006;95(2):362–372. doi: 10.1160/TH05-01-0047.</mixed-citation><mixed-citation xml:lang="en">Monagle P, Barnes C, Ignjatovic V, et al. Developmental haemostasis: impact for clinical haemostasis laboratories. Thromb Haemost. 2006;95(2):362–372. doi: 10.1160/TH05-01-0047.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Li JS, Yow E, Berezny KY, et al. Clinical outcomes of palliative surgery including a systemic-to-pulmonary artery shunt in infants with cyanotic congenital heart disease: does aspirin make a difference? Circulation. 2007;116(3):293–297. doi: 10.1161/CIRCULATIONAHA.106.652172.</mixed-citation><mixed-citation xml:lang="en">Li JS, Yow E, Berezny KY, et al. Clinical outcomes of palliative surgery including a systemic-to-pulmonary artery shunt in infants with cyanotic congenital heart disease: does aspirin make a difference? Circulation. 2007;116(3):293–297. doi: 10.1161/CIRCULATIONAHA.106.652172.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Manlhiot C, Brandao LR, Kwok J, et al. Thrombotic complications and thromboprophylaxis effectiveness across all 3 stages of univentricular heart palliation. Circulation. 2010;122(Suppl 21):A19711.</mixed-citation><mixed-citation xml:lang="en">Manlhiot C, Brandao LR, Kwok J, et al. Thrombotic complications and thromboprophylaxis effectiveness across all 3 stages of univentricular heart palliation. Circulation. 2010;122(Suppl 21):A19711.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Silvey M, Hall M, Bilynsky E, Carpenter SL. Increasing rates of thrombosis in children with congenital heart disease undergoing cardiac surgery. 2018 Feb;162:15-21. doi: 10.1016/j.thromres.2017.12.009.</mixed-citation><mixed-citation xml:lang="en">Silvey M, Hall M, Bilynsky E, Carpenter SL. Increasing rates of thrombosis in children with congenital heart disease undergoing cardiac surgery. 2018 Feb;162:15-21. doi: 10.1016/j.thromres.2017.12.009.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Emani S, Zurakowski D, Baird CW, et al. Hypercoagulability markers predict thrombosis in single ventricle neonates undergoing cardiac surgery. Ann Thorac Surg. 2013;96(2):651–656. doi: 10.1016/j.athoracsur.2013.04.061.</mixed-citation><mixed-citation xml:lang="en">Emani S, Zurakowski D, Baird CW, et al. Hypercoagulability markers predict thrombosis in single ventricle neonates undergoing cardiac surgery. Ann Thorac Surg. 2013;96(2):651–656. doi: 10.1016/j.athoracsur.2013.04.061.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Chen J, Zimmerman RA, Jarvik GP, et al. Perioperative stroke in infants undergoing open heart operations for congenital heart disease. Ann Thorac Surg. 2009;88(3):823–829. doi: 10.1016/j.athoracsur.2009.03.030.</mixed-citation><mixed-citation xml:lang="en">Chen J, Zimmerman RA, Jarvik GP, et al. Perioperative stroke in infants undergoing open heart operations for congenital heart disease. Ann Thorac Surg. 2009;88(3):823–829. doi: 10.1016/j.athoracsur.2009.03.030.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Block AJ, McQuillen PS, Chau V, et al. Clinically silent preoperative brain injuries do not worsen with surgery in neonates with congenital heart disease. J Thorac Cardiovasc Surg. 2010;140(3):550–557. doi: 10.1016/j.jtcvs.2010.03.035.</mixed-citation><mixed-citation xml:lang="en">Block AJ, McQuillen PS, Chau V, et al. Clinically silent preoperative brain injuries do not worsen with surgery in neonates with congenital heart disease. J Thorac Cardiovasc Surg. 2010;140(3):550–557. doi: 10.1016/j.jtcvs.2010.03.035.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">McQuillen PS, Barkovich AJ, Hamrick SE, et al. Temporal and anatomic risk profile of brain injury with neonatal repair of congenital heart defects. Stroke. 2007;38(2 Suppl):736–741. doi: 10.1161/01.STR.0000247941.41234.90.</mixed-citation><mixed-citation xml:lang="en">McQuillen PS, Barkovich AJ, Hamrick SE, et al. Temporal and anatomic risk profile of brain injury with neonatal repair of congenital heart defects. Stroke. 2007;38(2 Suppl):736–741. doi: 10.1161/01.STR.0000247941.41234.90.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Bertholdt S, Latal B, Liamlahi R, et al. Cerebral lesions on magnetic resonance imaging correlate with preoperative neurological status in neonates undergoing cardiopulmonary bypass surgery. Eur J Cardiothorac Surg. 2014;45(4):625–632. doi: 10.1093/ejcts/ezt422.</mixed-citation><mixed-citation xml:lang="en">Bertholdt S, Latal B, Liamlahi R, et al. Cerebral lesions on magnetic resonance imaging correlate with preoperative neurological status in neonates undergoing cardiopulmonary bypass surgery. Eur J Cardiothorac Surg. 2014;45(4):625–632. doi: 10.1093/ejcts/ezt422.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Silvey M, Hall M, Bilynsky E, Carpenter SL. Increasing rates of thrombosis in children with congenital heart disease undergoing cardiac surgery. Thromb Res. 2018;162:15–21. doi: 10.1016/j.thromres.2017.12.009.</mixed-citation><mixed-citation xml:lang="en">Silvey M, Hall M, Bilynsky E, Carpenter SL. Increasing rates of thrombosis in children with congenital heart disease undergoing cardiac surgery. Thromb Res. 2018;162:15–21. doi: 10.1016/j.thromres.2017.12.009.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
